Musculoskeletal health in newly diagnosed children with Crohn's disease

L M Ward1,2, J Ma3,4, F Rauch5

  • 1Pediatric Bone Health Clinical Research Program, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada. Lward@cheo.on.ca.

Insights

Newly diagnosed pediatric Crohn's disease (CD) patients exhibit significant muscle and bone deficits. Despite these deficits, vertebral fractures are uncommon at diagnosis, indicating a need for early musculoskeletal monitoring in children with CD.

Area of Science:

  • Pediatric rheumatology
  • Pediatric gastroenterology
  • Pediatric endocrinology

Background:

  • Crohn's disease (CD) is a chronic inflammatory condition impacting the gastrointestinal tract.
  • CD can lead to significant musculoskeletal complications, affecting bone and muscle health.
  • Early assessment of these complications in pediatric CD is crucial for long-term outcomes.

Purpose of the Study:

  • To evaluate the effects of newly diagnosed Crohn's disease on children's musculoskeletal system.
  • To determine the prevalence of vertebral fractures in this pediatric population.
  • To assess muscle and bone mass, strength, density, and geometry in children with newly diagnosed CD.

Main Methods:

  • Seventy-three children diagnosed with CD underwent assessment within 35 days of diagnosis.
  • Lateral spine radiography was used to detect vertebral fractures.
  • Jumping mechanography, dual-energy x-ray absorptiometry, and peripheral quantitative computed tomography (pQCT) evaluated muscle and bone parameters.

Main Results:

  • Children with newly diagnosed CD showed significantly low height, weight, BMI, and lean mass.
  • Bone mineral density and content were reduced, with pQCT revealing compromised bone structure.
  • Muscle strength and calf muscle cross-sectional area were diminished, despite a low prevalence of vertebral fractures (1 patient).

Conclusions:

  • Children newly diagnosed with Crohn's disease experience substantial deficits in muscle and bone health.
  • These deficits manifest as reduced mass, density, strength, and altered geometry.
  • Vertebral fractures are infrequent at the time of diagnosis in pediatric CD.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.3K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
960
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
598
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
568
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.1K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.7K